In terms of the SEBI (Prohibition of Insider Trading) Regulations, 2015 (‘the SEBI Regulations’), Code of Practices and Procedures for Prevention of Insider Trading and Code of Conduct & Fair Disclosure of Unpublished Price Sensitive Information (‘Company Code’) and SEBI Circular No. SEBI/HO/ISD/ISD/CIR/P/2020/135 dated July 23, 2020, Ind-Swift Laboratories has informed about the details of violation of the SEBI Regulations and Company Code by the Designated Person along with the action taken by the Company thereon is enclosed as ‘Annexure A’ to this letter.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1847.80 |
| Dr. Reddys Lab | 1289.05 |
| Cipla | 1408.00 |
| Zydus Lifesciences | 1067.95 |
| Lupin | 2351.20 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: